Filtern
Dokumenttyp
Schlagworte
- Driving (veh) (4)
- Fahrzeugführung (4)
- Deutschland (3)
- Forschungsbericht (3)
- Germany (3)
- Research report (3)
- Driver (2)
- Driving aptitude (2)
- Droge (2)
- Drugs (2)
- Fahrer (2)
- Fahrtauglichkeit (2)
- Time (2)
- Ablenkung (psychol) (1)
- Accident (1)
- Arzneimittel (1)
- Attention (1)
- Aufmerksamkeit (1)
- Behaviour (1)
- Benutzung (1)
- Braking (1)
- Bremsung (1)
- Dauer (Zeit) (1)
- Distraction (1)
- Fahrsimulator (1)
- Frequency (1)
- Häufigkeit (1)
- Interview (1)
- Lenken (Fahrzeug) (1)
- Measurement (1)
- Medical aspects (1)
- Medication (1)
- Medizinische Gesichtspunkte (1)
- Messung (1)
- Method (1)
- Mobile phone (1)
- Personality (1)
- Persönlichkeit (1)
- Reaction (human) (1)
- Reaktionsverhalten (1)
- Risikobewertung (1)
- Safety (1)
- Sample (stat) (1)
- Sicherheit (1)
- Simulator (driving) (1)
- Smartphone (1)
- Steering (process) (1)
- Stichprobe (1)
- Test (1)
- Unfall (1)
- Use (1)
- Verfahren (1)
- Verhalten (1)
- Versuch (1)
- Zeit (1)
Institut
- Sonstige (5) (entfernen)
Chronic non-cancer pain (CNCP) is a major health problem. Patients are increasingly treated with chronic opioid therapy (COT). Several laboratory studies have demonstrated that long-term use of opioids does not generally impair driving related skills. But there is still a lack of studies investigating on-the-road driving performance in actual traffic. The present study assessed the impact of COT on road-tracking and car-following performance in CNCP patients. Twenty CNCP patients, long-term treated with stable doses of opioid analgesics, and 19 healthy controls conducted standardized on-the-road driving tests in normal traffic. Performance of controls with a blood alcohol concentration (BAC) of 0.5 g/L was used as a reference to define clinically relevant changes in driving performance. Standard Deviation of Lateral Position (SDLP), a measure of road-tracking control, was 2.57 cm greater in CNCP patients than in sober controls. This difference failed to reach statistical significance in a superiority test. Equivalence testing indicated that the 95% CI around the mean SDLP change was equivalent to the SDLP change seen in controls with a BAC of 0.5 g/L and did not include zero. When corrected for age differences between groups the 95% CI widened to include both the alcohol reference criterion and zero. No difference was found in car-following performance. Driving performance of CNCP patients did not significantly differ from that of controls due to large inter-individual variations. Hence in clinical practice determination of fitness to drive of CNCP patients who receive opioid treatments should be based on an individual assessment.